These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. An update on the amyloid hypothesis. Eckman CB; Eckman EA Neurol Clin; 2007 Aug; 25(3):669-82, vi. PubMed ID: 17659184 [TBL] [Abstract][Full Text] [Related]
5. Gene mutations in inherited amyloidopathies of the nervous system. Tanzi RE Am J Hum Genet; 1991 Sep; 49(3):507-10. PubMed ID: 1831958 [No Abstract] [Full Text] [Related]
6. Lack of beta-amyloidosis in transgenic mice expressing low levels of familial Alzheimer's disease missense mutations. Malherbe P; Richards JG; Martin JR; Bluethmann H; Maggio J; Huber G Neurobiol Aging; 1996; 17(2):205-14. PubMed ID: 8744401 [TBL] [Abstract][Full Text] [Related]
7. Mutations in amyloid precursor protein gene and disease. Brown J Lancet; 1991 Apr; 337(8746):923-4. PubMed ID: 1673006 [No Abstract] [Full Text] [Related]
9. Amyloid-beta-induced degeneration of human brain pericytes is dependent on the apolipoprotein E genotype. Verbeek MM; Van Nostrand WE; Otte-Höller I; Wesseling P; De Waal RM Ann N Y Acad Sci; 2000 Apr; 903():187-99. PubMed ID: 10818507 [TBL] [Abstract][Full Text] [Related]
13. Characterization of amyloid fibril beta-peptide in familial Alzheimer's disease with APP717 mutations. Liepnieks JJ; Ghetti B; Farlow M; Roses AD; Benson MD Biochem Biophys Res Commun; 1993 Dec; 197(2):386-92. PubMed ID: 8267572 [TBL] [Abstract][Full Text] [Related]
14. Dominantly inherited dementia and parkinsonism, with non-Alzheimer amyloid plaques: a new neurogenetic disorder. Rosenberg RN; Green JB; White CL; Sparkman DR; DeArmond SJ; Kepes JJ Ann Neurol; 1989 Feb; 25(2):152-8. PubMed ID: 2645825 [TBL] [Abstract][Full Text] [Related]
15. Presentation of amyloidosis in carriers of the codon 692 mutation in the amyloid precursor protein gene (APP692). Roks G; Van Harskamp F; De Koning I; Cruts M; De Jonghe C; Kumar-Singh S; Tibben A; Tanghe H; Niermeijer MF; Hofman A; Van Swieten JC; Van Broeckhoven C; Van Duijn CM Brain; 2000 Oct; 123 ( Pt 10)():2130-40. PubMed ID: 11004129 [TBL] [Abstract][Full Text] [Related]
16. Neuropathology in the Down's syndrome brain. Tanzi RE Nat Med; 1996 Jan; 2(1):31-2. PubMed ID: 8564833 [No Abstract] [Full Text] [Related]
17. Alzheimer disease and the prion disorders amyloid beta-protein and prion protein amyloidoses. Price DL; Borchelt DR; Sisodia SS Proc Natl Acad Sci U S A; 1993 Jul; 90(14):6381-4. PubMed ID: 8101988 [TBL] [Abstract][Full Text] [Related]
18. Cognitive and emotional alterations in App knock-in mouse models of Aβ amyloidosis. Sakakibara Y; Sekiya M; Saito T; Saido TC; Iijima KM BMC Neurosci; 2018 Jul; 19(1):46. PubMed ID: 30055565 [TBL] [Abstract][Full Text] [Related]
19. The 7th Leonard Berg Symposium, Part 3. Strobel G J Alzheimers Dis; 2010; 21(1):315-21. PubMed ID: 20657051 [No Abstract] [Full Text] [Related]
20. Natural Phenolic Compounds as Therapeutic and Preventive Agents for Cerebral Amyloidosis. Yamada M; Ono K; Hamaguchi T; Noguchi-Shinohara M Adv Exp Med Biol; 2015; 863():79-94. PubMed ID: 26092627 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]